👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Is This The Calm Before The Storm?

Published 23/03/2017, 11:08 am
USD/ZAR
-
XAU/USD
-
US500
-
AXJO
-
BHP
-
CBA
-
GC
-
FVH25
-
DXY
-
=AUD
-

Originally published by IG Markets

After all the excitement yesterday, confirming that all financial markets do actually have a pulse and that they can actually fall, we should see more reserved conditions today.

Whether we’re seeing the ‘calm before the storm’ was the question asked yesterday. Remember this is a market that is still so full of complacency, and clearly long equities and short US Treasuries. The prospect of increased volatility is real, although that proposition still sounds too good to be true, at least for the traders out there. Calmer conditions and leads have been offered for Asia though, and with perhaps the exception of Japan, we should see a modest upside to the various Asian indices, but there won’t be any real conviction behind the buying.

This was thematic yesterday, where there were so few buyers and the markets fell under their own weight. Has the overnight session provided any clarity and renewed optimism to wade in? I don’t believe so.

So once again financial strategists become political pundits, as we try and assess the probability of House Speaker Paul Ryan’s healthcare plan being passed through the House. We know the Republicans hold 237 of the 430 seats in the House (or 55.1%) and effectively need 216 votes to get the required majority. However, Alyssa Farah, spokesperson for the Freedom Caucus (the collective who want Obamacare to be completely torn apart and reworked), has suggested that they have 25 hard ‘no’ votes, and Trump and Ryan cannot afford any more than 21. This suggests Trump/Ryan would be four votes shy of the required tally to get the bill over the line, given every Democrat will vote against this bill.

Clearly, the Freedom Caucus want their time in the sun and want to be heard. This could be the second big loss for President Trump after his immigration order was rejected. This vote then during Asian trade tomorrow (no set time as of yet - http://www.house.gov/) will be seen as a proxy for the strength of the mandate that Trump has had to govern. There is no tax reform without the Ryan healthcare plan voted through. However, the likelihood is that it will be reworked and voted on again in the future. This is a key event risk for tomorrow, and as I mention, likely to keep the buyers in Asia at bay.

If we look at other markets to view semantics, we can see small buying in US fixed income, with the US five-year Treasury falling a couple of basis points to 1.93%, and the five-year ‘real’ yields still just in negative territory. The US Dollar Index is largely unchanged, but is still holding under the 100 level. Even though we have seen some buying in the likes of the ZAR and other emerging market currencies, the Australian dollar has certainly not fared as well, although is now eyeing a move back into the trading session highs of $0.7691. Small buying has also been seen in high yield credit, with the Shares High Yield Corporate Exchange Traded Fund (HYG ETF) gaining 0.3%.

It all suggests calmer conditions from the prior session, but as I mention, it’s all about tomorrow. It would be interesting if we actually saw the Bill being passed, followed by a strong (February) durables goods data (consensus 1.3%). New York Fed president Bill Dudley speaks at 1.00am AEDT on Saturday morning and if he talks up the prospect of a June Fed hike, given financial conditions are still so accommodative, then things will get very interesting. Obviously a lot of hypotheticals, but do we start saying the reflation trade is back on if this scenario plays out? These are fickle markets.

Turning to the Asian open, it’s interesting that SPI futures have pushed up 17 points, largely as a function that S&P 500 futures are 8 points, or 0.4% higher from the S&P/ASX 200close. So a number of traders who had positioned for another night of fairly heavy selling have likely closed out of SPI futures shorts.

As far as sector leads go in the S&P 500, the buying really centred on tech. This won’t really help the ASX 200 too greatly. US financials and materials are largely unchanged, but BHP Billiton Ltd's (AX:BHP) ADR (American Depository Receipt) is up 0.8%. Commonwealth Bank Of Australia's. (AX:CBA) ADR is 0.5%. Commodity leads are mixed, with spot iron ore falling 3% to $84.99 and the days of calling $100 spot prices seem a distant memory. Iron ore and steel futures (traded on the Dalian exchange) has pulled back 1% and 0.2% respectively. Gold is modestly high, as is US crude, which is actually around 20c higher from the ASX 200 close, despite a 4.95 million barrel increase in the weekly (official) inventory data. The offset being a sizeable draw in gasoline inventories of 2.81 million.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.